Tykerb and Herceptin for Breast Cancer - Health Blog - WSJ
Links shared publicly online about this topic.
- 1,537total visits
Tykerb and Herceptin for Breast Cancer - Health Blog - WSJ
View full resource at blogs.wsj.com
Tags: Cancer, Cancer Medication, Breast Cancer, Breast Cancer Medication, Drug, Women's Health, Herceptin
Most Recently Shared on December 11, 2009 at 9:59 pm By:
Combining Targeted Breast Cancer Drugs for Very Sick Patients http://bit.ly/8vn4P2
Medical News: Lapatinib Fails as Breast Cancer Monotherapy - in Oncology/Hematology, Breast Cancer from MedPage Today
medpagetoday.com — “Patients receiving lapatinib (Tykerb) as adjuvant monotherapy for early, HER2-positive breast cancer had poorer outcomes than those on trastuzumab (Herceptin) in a head-to-head trial, leading its spon” View full resource at medpagetoday.com
Most Recently Shared on September 9, 2011 at 5:02 pm By:
Lapatinib Fails as Breast Cancer Monotherapy: (MedPage Today) -- Patients receiving lapatinib… http://t.co/CDCIE03
Lapatinib Fails as Breast Cancer Monotherapy - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Patients receiving lapatinib (Tykerb) as adjuvant monotherapy for early, HER2-positive breast cancer had poorer outcomes than those on trastuzumab (Herceptin) in a head-to-head trial, leading its sponsor to stop that arm of the study.” View full resource at qualitypointtech.net
Most Recently Shared on September 9, 2011 at 5:00 pm By:
Lapatinib Fails as Breast Cancer Monotherapy: (MedPage Today) -- Patients receiving lapatinib (Tykerb) as adjuvant... http://t.co/k4IJknL
Breast Cancer? But Doctor....I hate pink!: xkcd: Lanes
butdoctorihatepink.com — “Breast Cancer Survivor, Ann Silberman, writes a humorous breast cancer blog while undergoing mastectomy, chemotherapy, herceptin, and reconstruction” View full resource at butdoctorihatepink.com
Most Recently Shared on July 31, 2011 at 1:55 am By:
Great & relevant comic! RT @ButDocIHatePink xkcd: Lanes http://bit.ly/p3U6xE #cancer #breastcancer #bcsm #survivorship
U.K. cost watchdog rejects Roche, GSK cancer meds - FiercePharma
fiercepharma.com — “The U.K. hasn't been kind to high-tech cancer drugs this week: The cost-effectiveness watchdog NICE rejected Roche's Herceptin and GlaxoSmithKline's Tykerb for use in breast cancer patients in... Read more...” View full resource at fiercepharma.com
Most Recently Shared on December 15, 2010 at 4:08 pm By:
U.K. cost watchdog rejects Roche, GSK cancer meds http://bit.ly/fPtgXR
Medical News: SABCS: HER2-Targeted Drugs Not Equal in Breast CA - in Meeting Coverage, SABCS from MedPage Today
medpagetoday.com — “SAN ANTONIO -- For presurgical treatment of HER2-positive early breast cancer, lapatinib (Tykerb) doesn't measure up to standard trastuzumab (Herceptin), according to head-to-head trial results.” View full resource at medpagetoday.com
Most Recently Shared on December 11, 2010 at 6:15 pm By:
SABCS: HER2-Targeted Drugs Not Equal in Breast CA (CME/CE) http://bit.ly/gy9hDh
Medical News: SABCS: HER2-Targeted Drugs Not Equal in Breast CA - in Meeting Coverage, SABCS from MedPage Today
medpagetoday.com — “SAN ANTONIO -- For presurgical treatment of HER2-positive early breast cancer, lapatinib (Tykerb) doesn't measure up to standard trastuzumab (Herceptin), according to head-to-head trial results.” View full resource at medpagetoday.com
Most Recently Shared on December 11, 2010 at 6:11 pm By:
SABCS: HER2-Targeted Drugs Not Equal in Breast CA (CME/CE) http://bit.ly/hmCMgD
Drug combo helps women with early breast cancer
physorg.com — “(AP) -- A new study finds that using two drugs, Herceptin (her-SEPT-in) and Tykerb (TIE-curb), more than doubles the number of women with early breast cancer whose tumors disappear before they are scheduled to have surgery to remove them.” View full resource at physorg.com
Most Recently Shared on December 10, 2010 at 4:33 pm By:
Drug combo helps women with early breast cancer http://bit.ly/dIxdp0
Drug combo helps women with early breast cancer
health.yahoo.net — “A new study finds that using two drugs, Herceptin (her-SEPT-in) and Tykerb (TIE-curb), more than doubles the number of women with early breast cancer whose tumors disappear before they are scheduled to have surgery to remove them.” View full resource at health.yahoo.net
Most Recently Shared on December 10, 2010 at 2:55 pm By:
Jane Anderson Healthy Eating Advisor
Drug combo helps women with early breast cancer http://bit.ly/f7Vh2X
Study: Herceptin plus Tykerb helps women with early breast cancer more than either drug alone | StarTribune.com
startribune.com — “Study: Herceptin plus Tykerb helps women with early breast cancer more than either drug alone | StarTribune.com” View full resource at startribune.com
Most Recently Shared on December 10, 2010 at 2:27 pm By:
Study: Herceptin plus Tykerb helps women with early breast cancer more than either drug alone: http://bit.ly/hfCOQ5
Herceptin And Tykerb Effective Against A Subset Of Gastric Cancers
medicalnewstoday.com — “A combination of two targeted therapies already shown to be effective in breast cancer packs an effective one-two punch against a subset of gastric cancers that have a specific genetic mutation, a” View full resource at medicalnewstoday.com
Most Recently Shared on March 3, 2010 at 7:13 pm By:
MNT Gastrointestinal Health News
Herceptin And Tykerb Effective Against A Subset Of Gastric Cancers http://mnt.to/3ypT #gastrointestinal
Herceptin and Tykerb effective against a subset of gastric cancers
physorg.com — “A combination of two targeted therapies already shown to be effective in breast cancer packs an effective one-two punch against a subset of gastric cancers that have a specific genetic mutation, a study at UCLA's Jonsson Comprehensive Cancer Center has found.” View full resource at physorg.com
Most Recently Shared on March 3, 2010 at 2:07 pm By:
PhysOrg Health News Health News
Herceptin and Tykerb effective against a subset of gastric cancers http://tw.physorg.com/186829559
Combination therapy improves overall survival in women with advanced breast cancer
news-medical.net — “In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB® (lapatinib) plus HERCEPTIN® (trastuzumab). The results of the Phase III study in HER2-positive metastatic breast cancer were presented during the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held in San Antonio, Texas (Dec. 9 - 13).” View full resource at news-medical.net
Most Recently Shared on December 14, 2009 at 8:49 am By:
Pregnancy News: Combination therapy improves overall survival in women with advanced breast cancer: In a clinical s... http://bit.ly/4YUecr
For Some Women, Aggressive Treatment for Early Breast Cancer - Well Blog - NYTimes.com
twshot.com — “For Some Women, Aggressive Treatment for Early Breast Cancer - Well Blog - NYTimes.com” View full resource at twshot.com
Most Recently Shared on December 14, 2008 at 1:44 am By:
marcin chwistek Doctor, Internist, Pain Medicine Physician, and Physician
New info about Herceptin in subpopulation of women with breast cancer. http://twshot.com/?6LQ
Advertisement
